Literature DB >> 15084212

Vectorcardiography risk stratifies emergency department chest pain patients with left ventricular hypertrophy on the initial 12-lead ECG.

Francis M Fesmire1, Sven V Eriksson.   

Abstract

BACKGROUND: Vectorcardiographic (VCG) measurements of ST-vector magnitude (VM) and QRS-vector difference (VD) have been demonstrated to be independent predictors of adverse outcome (AO) and acute myocardial infarction (AMI) in emergency department (ED) chest pain patients with absence of bundle branch block or left ventricular hypertrophy (LVH) on the initial 12-lead electrocardiogram (ECG). The prognostic value of ST-VM and QRS-VD in ED chest pain patients with LVH on the initial 12-lead ECG has not been previously investigated.
METHODS: A prospective observational study was performed in 196 consecutive ED chest pain patients with suspected AMI and presence of voltage criteria for LVH on initial ECG who underwent continuous VCG monitoring during the initial evaluation. The optimal baseline ST-VM value and 2-hour QRS-VD value were defined as the most accurate value on the receiver operator characteristic curve (value with lowest false-negative and false-positive rate). Thirty-day AO was defined as AMI, percutaneous coronary intervention, coronary artery bypass grafting (CABG), or cardiac death occurring within 30 days of initial ED visit.
RESULTS: Fourteen patients (7.1%) were diagnosed as 24-hour AMI and 28 patients (14.3%) experienced 30-day AO. The optimal cut-off value for predicting 30-day AO was > 124 microV for ST-VM and > 21.7 microV for QRS-VD. Patients with either a positive ST-VM or a positive QRS-VD had 8.8 times increased odds of AMI (95% confidence interval, CI, 1.9-40.3; P = 0.003); 4.3 times increased odds of 30-day PTCA/CABG (95% CI 1.3-13.8; P = 0.019); and 3.8 times increased odds of 30-day AO (95% CI 1.6-9.3; P = 0.003).
CONCLUSIONS: Baseline ST-VM and 2-hour QRS-VD risk stratifies ED chest pain patients with LVH voltage criteria on the initial 12-lead ECG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084212      PMCID: PMC6932677          DOI: 10.1111/j.1542-474X.2004.92536.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  34 in total

1.  An accurate, clinically practical system for spatial vectorcardiography.

Authors:  E FRANK
Journal:  Circulation       Date:  1956-05       Impact factor: 29.690

2.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

3.  Electrocardiographic manifestations: patterns that confound the EKG diagnosis of acute myocardial infarction-left bundle branch block, ventricular paced rhythm, and left ventricular hypertrophy.

Authors:  W J Brady; T C Chan; M Pollack
Journal:  J Emerg Med       Date:  2000-01       Impact factor: 1.484

4.  Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Authors:  A Langer; M W Krucoff; P Klootwijk; R Veldkamp; M L Simoons; C Granger; R M Califf; P W Armstrong
Journal:  J Am Coll Cardiol       Date:  1995-06       Impact factor: 24.094

5.  Selective dual nuclear scanning in low-risk patients with chest pain to reliably identify and exclude acute coronary syndromes.

Authors:  F M Fesmire; A D Hughes; P K Stout; J F Wojcik; D R Wharton
Journal:  Ann Emerg Med       Date:  2001-09       Impact factor: 5.721

6.  Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram.

Authors:  D J Patel; D R Holdright; C J Knight; D Mulcahy; B Thakrar; C Wright; J Sparrow; M Wicks; W Hubbard; R Thomas; G C Sutton; G Hendry; H Purcell; K Fox
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

7.  Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment.

Authors:  K Andersen; M Dellborg; H Emanuelsson; L Grip; K Swedberg
Journal:  Coron Artery Dis       Date:  1996-09       Impact factor: 1.439

8.  Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia--its influence on diagnosis, triage, and short-term prognosis: a multicenter study.

Authors:  G C Larsen; J L Griffith; J R Beshansky; R B D'Agostino; H P Selker
Journal:  J Gen Intern Med       Date:  1994-12       Impact factor: 5.128

9.  The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes.

Authors:  Francis M Fesmire; Alan D Hughes; Edward P Fody; Alan P Jackson; Connie E Fesmire; Mark A Gilbert; Paul K Stout; James F Wojcik; David R Wharton; James H Creel
Journal:  Ann Emerg Med       Date:  2002-12       Impact factor: 5.721

10.  Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

Authors:  H Tunstall-Pedoe; K Kuulasmaa; P Amouyel; D Arveiler; A M Rajakangas; A Pajak
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.